Exportar registro bibliográfico


Metrics:

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial (2017)


Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2021